Levothyroxine Sodium Tablet
Product Images NDC 82804-277

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 82804-277). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (94052e3d 58b2 4f4b 8223 A47281c1a592 01)

FDA Label Image

Trade Mark (94052e3d 58b2 4f4b 8223 A47281c1a592 02)

Trade Mark (94052e3d 58b2 4f4b 8223 A47281c1a592 02)
"LUPIN and the .%. are registered trademarks of Lupin Pharmaceuticals, Inc." - This text indicates that the terms "LUPIN" and ".%" are registered trademarks of Lupin Pharmaceuticals, Inc. It is important to respect the intellectual property rights associated with these trademarks.*
FDA Label Image

82804-277-30 (Image 01)

82804-277-30 (Image 01)
This is a detailed description of a medication called Levothyroxine Sodium. It comes in tablet form, with each tablet containing 112 mcg (0.112 mg) of Levothyroxine Sodium USP. The tablets are round, rose-colored, scored, and debossed with L21 on one side and a break line on the other side. The medication is manufactured by Lupin Limited in India. It is essential to store it at 25°C (77°F) and keep it out of the reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.